I noticed the DIPG Phase I end data is in. This data must be...

I noticed the DIPG Phase I end data is in. This data must be coming soon the other trials are a way off though. I know data is your thing interested in your thoughts.

	Study Type:	Interventional (Clinical Trial)
1	ActualEnrollment:	27 participants
2	Allocation:	Non-Randomized
3	Intervention Model:	Parallel Assignment
4	Masking:	None (Open Label)
5	Primary Purpose:	Treatment
6	Official Title:	Phase I Study of GDC-0084, a Brain-Penetrant PI3 Kinase/mTOR Inhibitor, in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas After Radiation Therapy
7	ActualStudy Start Date:	November 19, 2018
8	ActualPrimary Completion Date:	April 2, 2021
9	EstimatedStudy Completion Date:	June 2023